Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non–Small-Cell Lung Cancer

Overview of attention for article published in Journal of Clinical Oncology, October 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter: 39 X users
patent: 11 patents

reddit: 1 Redditor

Citations

dimensions_citation: 349 Dimensions

Readers on

mendeley: 213 Mendeley

Summary X Patents Reddit Dimensions citations

So far, Altmetric has seen 44 X posts from 39 X users, with an upper bound of 206,293 followers.

Programmed Death-Ligand 1 (PD-L1) Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in NSCLC [12/2017] Büttner et al. @JCO_ASCO https://t.co/Pex6fiq0li #lcsm #ImmunoOnc HT @rschilsky

28 Feb 2019

Reply Repost Favourite

RT @cancerassassin1: There remains too much variability in sensitivity/accuracy of assays assessing PDL-1 expression. Review in @JCO_ASCO :…

30 Nov 2017

Reply Repost Favourite

RT @rschilsky: Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non–Sma…

29 Nov 2017

Reply Repost Favourite

RT @rschilsky: Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non–Sma…

29 Nov 2017

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 40 additional X posts.